Curanex Pharmaceuticals Inc stock is traded at $5.78, with a volume of 7,967. It is down -0.34% in the last 24 hours and up +15.83% over the past month. Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.
Previous Close:
$5.80
Open:
$5.64
24h Volume:
7,967
Relative Volume:
0.54
Market Cap:
$9.06M
Revenue:
-
Net Income/Loss:
-$7.24M
P/E Ratio:
-
EPS:
-$0.2554
Net Cash Flow:
-$11.29M
1W Performance:
+12.02%
1M Performance:
+15.83%
6M Performance:
-18.01%
1Y Performance:
-52.83%
1-Day Range:
$0.00$0.00
1-Week Range:
$5.40$6.20
52-Week Range:
$3.58$13.44
Curanex Pharmaceuticals Inc Stock (CURX) Company Profile
Name
Curanex Pharmaceuticals IncSector
HealthcareIndustry
BiotechnologyPhone
718-673-6078Address
2 JERICHO PLAZA,, JERICHO, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS